tradingkey.logo

Envoy Medical Inc

COCH
0.471USD
-0.051-9.85%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
11.23MCap. mercado
PérdidaP/E TTM

Envoy Medical Inc

0.471
-0.051-9.85%

Más Datos de Envoy Medical Inc Compañía

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Información de Envoy Medical Inc

Símbolo de cotizaciónCOCH
Nombre de la empresaEnvoy Medical Inc
Fecha de salida a bolsaMar 02, 2021
Director ejecutivoLucas (Brent T)
Número de empleados42
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 02
Dirección4875 White Bear Parkway
CiudadWHITE BEAR LAKE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55110
Teléfono16513618000
Sitio Webhttps://www.envoymedical.com/
Símbolo de cotizaciónCOCH
Fecha de salida a bolsaMar 02, 2021
Director ejecutivoLucas (Brent T)

Ejecutivos de Envoy Medical Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
234.59K
-2578.00%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
234.59K
-2578.00%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--

Desglose de ingresos

La empresa aún no ha revelado los datos relevantes.
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: jue., 5 de feb
Actualizado: jue., 5 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Taylor (Glen A)
35.75%
Atlas Merchant Capital LLC
1.93%
The Vanguard Group, Inc.
1.21%
Weiss Asset Management
0.84%
Lucas (Brent T)
0.81%
Otro
59.46%
Accionistas
Accionistas
Proporción
Taylor (Glen A)
35.75%
Atlas Merchant Capital LLC
1.93%
The Vanguard Group, Inc.
1.21%
Weiss Asset Management
0.84%
Lucas (Brent T)
0.81%
Otro
59.46%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
37.07%
Investment Advisor
2.67%
Private Equity
1.93%
Investment Advisor/Hedge Fund
1.27%
Hedge Fund
1.23%
Research Firm
0.06%
Otro
55.76%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
47
2.25M
9.80%
+81.14K
2025Q3
59
2.17M
17.45%
-288.93K
2025Q2
64
2.46M
24.39%
+3.06K
2025Q1
70
2.46M
24.73%
-2.82M
2024Q4
143
2.12M
158.30%
+927.59K
2024Q3
151
1.20M
185.14%
-129.06K
2024Q2
157
1.33M
194.46%
+97.08K
2024Q1
156
1.23M
199.37%
-37.85M
2023Q4
150
1.71M
201.29%
-1.36M
2023Q3
149
3.06M
201.92%
-985.94K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Taylor (Glen A)
10.29M
35.75%
--
--
Dec 18, 2025
Atlas Merchant Capital LLC
555.53K
1.93%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
339.11K
1.18%
-55.85K
-14.14%
Sep 30, 2025
Weiss Asset Management
242.64K
0.84%
-125.50K
-34.09%
Sep 30, 2025
Lucas (Brent T)
237.17K
0.82%
+2.58K
+1.10%
Dec 18, 2025
Focus Partners Wealth, LLC
212.66K
0.74%
--
--
Sep 30, 2025
Arcus Capital Partners, LLC
152.87K
0.53%
-34.70K
-18.50%
Sep 30, 2025
Meteora Capital LLC
108.51K
0.38%
+81.14K
+296.46%
Oct 17, 2025
Kantor (Susan J.)
77.89K
0.27%
--
--
Dec 18, 2025
CIBC Private Wealth Management
77.89K
0.27%
--
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI